Article Versions Notes

Sanchez A, Vidal CM, Chávez NR, Jinna N, Alva-Ornelas J, Robles VM, Resto C, Sanchez N, Aljaber D, Monge M, et al. Mixed-Methods Approach: Impact of Clinical Consenter Diversity on Clinical Trials Enrollment. Cancers. 2025; 17(6):1043. https://doi.org/10.3390/cancers17061043

Sanchez, Angelica, Christina M. Vidal, Noé Rubén Chávez, Nikita Jinna, Jackelyn Alva-Ornelas, Vanessa Myriam Robles, Cristal Resto, Nancy Sanchez, Dana Aljaber, Margarita Monge, and et al. 2025. "Mixed-Methods Approach: Impact of Clinical Consenter Diversity on Clinical Trials Enrollment" Cancers 17, no. 6: 1043. https://doi.org/10.3390/cancers17061043

Sanchez, A., Vidal, C. M., Chávez, N. R., Jinna, N., Alva-Ornelas, J., Robles, V. M., Resto, C., Sanchez, N., Aljaber, D., Monge, M., Ramirez, A., Reyes, A., Martinez, E., Jones, V. C., Tomsic, J., Davis, K. A., & Seewaldt, V. L. (2025). Mixed-Methods Approach: Impact of Clinical Consenter Diversity on Clinical Trials Enrollment. Cancers, 17(6), 1043. https://doi.org/10.3390/cancers17061043